Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Circulation
|
October 22, 2003
Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia
A Greinacher, N Lubenow, P Eichler
Reviews in Clinical and Experimental Hematology
|
November 13, 2001
Drug-induced and drug-dependent immune thrombocytopenias
A Greinacher, P Eichler, N Lubenow, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 26, 2005
Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3
N Lubenow, P Eichler, T Lietz, et al.
Thrombosis and Haemostasis
|
July 4, 2001
A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia
B Farner, P Eichler, H Kroll, et al.
Blood
|
January 15, 1998
Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients
J Polgár, P Eichler, A Greinacher, et al.
Transfusion Medicine (Oxford, England)
|
February 17, 2006
Post-transfusion purpura in a patient with HPA-1a and GPIa/IIa antibodies
C Woelke, P Eichler, G Washington, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
September 10, 1999
[Difficulties of fungus detection in corneal culture medium]
G Jendral, F Wilhelm, H Bernhardt, et al.
Blood
|
July 27, 2000
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range
A Greinacher, P Eichler, N Lubenow, et al.
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete
|
March 21, 1998
[Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II]
D Ganzer, A Gutezeit, G Mayer, et al.
Blood
|
September 26, 2000
Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance
P Eichler, H J Friesen, N Lubenow, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Circulation
|
October 22, 2003
Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia
A Greinacher, N Lubenow, P Eichler
Reviews in Clinical and Experimental Hematology
|
November 13, 2001
Drug-induced and drug-dependent immune thrombocytopenias
A Greinacher, P Eichler, N Lubenow, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 26, 2005
Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3
N Lubenow, P Eichler, T Lietz, et al.
Thrombosis and Haemostasis
|
July 4, 2001
A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia
B Farner, P Eichler, H Kroll, et al.
Blood
|
January 15, 1998
Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients
J Polgár, P Eichler, A Greinacher, et al.
Transfusion Medicine (Oxford, England)
|
February 17, 2006
Post-transfusion purpura in a patient with HPA-1a and GPIa/IIa antibodies
C Woelke, P Eichler, G Washington, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
September 10, 1999
[Difficulties of fungus detection in corneal culture medium]
G Jendral, F Wilhelm, H Bernhardt, et al.
Blood
|
July 27, 2000
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range
A Greinacher, P Eichler, N Lubenow, et al.
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete
|
March 21, 1998
[Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II]
D Ganzer, A Gutezeit, G Mayer, et al.
Blood
|
September 26, 2000
Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance
P Eichler, H J Friesen, N Lubenow, et al.
Page
of 3